FDA’s Dr. Martin Makary says drug ads have crossed the line and enforcement is needed, calling out pharmaceutical companies for spending 20-25% of their budgets on marketing.

Diane Swonk, chief economist at KPMG, responded to the Federal Reserve’s rate cut decision on Wednesday and discussed expectations for future FOMC meetings this year.